2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Sales - EUR | 10.879 | 11.186 | 10.054 | 8.813 | 14.511 | 24.363 | 20.978 | 26.329 | 24.805 | 21.057 |
Total Income - EUR | 10.879 | 11.186 | 10.054 | 8.813 | 14.511 | 24.363 | 22.227 | 26.580 | 24.805 | 21.057 |
Total Expenses - EUR | 17.025 | 11.754 | 14.904 | 19.223 | 18.171 | 20.116 | 18.886 | 21.454 | 15.980 | 10.615 |
Gross Profit/Loss - EUR | -6.146 | -568 | -4.850 | -10.410 | -3.660 | 4.247 | 3.341 | 5.126 | 8.825 | 10.442 |
Net Profit/Loss - EUR | -6.473 | -904 | -5.109 | -10.504 | -3.806 | 4.003 | 3.131 | 4.860 | 8.340 | 8.648 |
Employees | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 0 |
Check the financial reports for the company - Clinilab Neacsu S.r.l.
2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Fixed Assets | 850 | 252 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Current Assets | 151 | 499 | 45 | 63 | 1.507 | 3.101 | 509 | 1.728 | 2.449 | 582 |
Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash | 151 | 499 | 45 | 63 | 1.507 | 3.101 | 509 | 1.728 | 2.449 | 582 |
Shareholders Funds | -14.107 | -15.128 | -20.083 | -30.247 | -33.498 | -28.846 | -25.168 | -19.750 | -11.471 | -2.788 |
Social Capital | 45 | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 |
Debts | 15.109 | 15.879 | 20.128 | 30.311 | 35.005 | 31.947 | 25.677 | 21.478 | 13.920 | 3.370 |
Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Exchange rate - RON | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 | 4.4821 |
Main CAEN | "8690 - 8690" | |||||||||
CAEN Financial Year |
8690
|
Subscriptions Financial Reports
You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.
Comments - Clinilab Neacsu S.r.l.